TIMOTHY M. RING - 03 Oct 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Role
Director
Signature
/s/ William J. O'Shaughnessy, Jr., attorney in fact for Timothy M. Ring
Issuer symbol
DGX
Transactions as of
03 Oct 2022
Net transactions value
-$246,780
Form type
4
Filing time
04 Oct 2022, 16:34:53 UTC
Previous filing
06 Sep 2022
Next filing
02 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Options Exercise $122,450 +2,000 +8.4% $61.22 25,933 03 Oct 2022 Direct F1
transaction DGX Common Stock Sale $246,780 -2,000 -7.7% $123.39 23,933 03 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Stock Options (Right to Buy) Options Exercise $122,450 -2,000 -88% $61.22 260 03 Oct 2022 Common Stock 2,000 $61.22 Direct F1, F2
transaction DGX Phantom Stock Units Award $0 +333 +2.7% $0.000000 12,748 03 Oct 2022 Common Stock 333 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 1, 2022.
F2 The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.
F3 Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.
F4 Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.